Stocks: 503 Market Cap: $51.2T S&P 500: 5,954.50 +0.82%
500 500Market
Viatris
VTRS Rank #420 Health Care
$15.05 +0.78%

Key Statistics

Market Cap
$17.37B
Volume (24h)
$144.0M
P/E Ratio
N/A
EPS
N/A
1 Day
+0.78%
7 Day
-5.49%
YTD
-10.98%
Sector
Health Care
S&P 500 Rank
#420
52W Low: $12.19 52W High: $18.51

About Viatris

Viatris is a global healthcare company that develops, manufactures, and markets a diverse portfolio of prescription products, including generic and branded medicines, vaccines, and over-the-counter (OTC) products. The company's product lineup includes a range of therapeutic areas, including cardiovascular, infectious diseases, and oncology, among others. As a leading player in the generic and biosimilar markets, Viatris plays a critical role in increasing access to affordable medicines globally.

Latest News

Loading latest news...

Sector Peers — Health Care

LLY — Lilly (Eli) $1,027.59 -2.32% JNJ — Johnson & Johnson $247.67 -0.31% ABBV — AbbVie $233.22 +0.49% MRK — Merck & Co. $121.20 -2.11% UNH — UnitedHealth Group $290.56 -0.92% AMGN — Amgen $384.71 -0.89% ABT — Abbott Laboratories $114.46 -1.62% TMO — Thermo Fisher Scientific $506.43 -2.82% View all Health Care stocks →

Daily Market Brief

S&P 500 closing prices, top movers, and sector performance — delivered daily.